Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials-Reference-Cited by-同舟云学术

Associations between hematologic toxicity and health-related quality of life during first-line chemotherapy in advanced non-small-cell lung cancer: a pooled analysis of two randomized trials

Published:2018-08-03 Issue:11 Volume:57 Page:1574-1579
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Kristensen Are¹²^ORCID,Solheim Tora Skeidsvoll¹²^ORCID,Fløtten Øystein³,Grønberg Bjørn Henning¹²^ORCID

Affiliation:

1. European Palliative Care Research Centre (PRC), Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, NTNU, Norwegian University of Science and Technology, Trondheim, Norway;

2. Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway;

3. Department of Thoracic Medicine, Haukeland University Hospital, Bergen, Norway

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/0284186X.2018.1492151

Reference21 articles.

1. Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

2. Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

3. The symptom burden of non-small cell lung cancer in the USA: a real-world cross-sectional study